{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,30]],"date-time":"2026-03-30T03:55:52Z","timestamp":1774842952880,"version":"3.50.1"},"reference-count":54,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020,3]]},"abstract":"<jats:sec><jats:title>Purpose of review<\/jats:title><jats:p>To review advances in the understanding of potentially causal relationships between gout, hyperuricemia and comorbidities.<\/jats:p><\/jats:sec><jats:sec><jats:title>Recent findings<\/jats:title><jats:p>Observational studies reveal 4\u20135 comorbidity clusters in gout patients. There tend to be gout alone, gout with chronic kidney disease and gout with other metabolic comorbidities. However, heterogeneous study populations and confounding make inference difficult for causal relationships. Mendelian randomization leverages genetic information as an instrumental variable to indicate putatively causal relationships between traits of epidemiological interest. Thus far, Mendelian randomization has not indicated widespread causal relationships of serum urate for comorbid traits. However, BMI has a small causal effect on serum urate, which may partially explain the increased prevalence of metabolic syndrome and cardiovascular disease among those with gout and hyperuricemia. There is a lack of robust and sufficiently powered Mendelian randomization studies for many serum urate-associated traits, such as hypertension. No adequately powered studies have been completed for gout and its comorbidities.<\/jats:p><\/jats:sec><jats:sec><jats:title>Summary<\/jats:title><jats:p>Although observational studies indicate putative causal effects of serum urate on comorbidities, Mendelian randomization studies suggest that serum urate does not have a causal role on the various tested comorbidities. There remains work to be done in clarifying the causal role of gout per se on the same traits.<\/jats:p><\/jats:sec>","DOI":"10.1097\/bor.0000000000000691","type":"journal-article","created":{"date-parts":[[2019,12,24]],"date-time":"2019-12-24T19:37:32Z","timestamp":1577216252000},"page":"126-133","source":"Crossref","is-referenced-by-count":38,"title":["Comorbidities in gout and hyperuricemia: causality or epiphenomena?"],"prefix":"10.1097","volume":"32","author":[{"given":"Nicholas A.","family":"Sumpter","sequence":"first","affiliation":[{"name":"Department of Biochemistry, University of Otago, Dunedin, New Zealand"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kenneth G.","family":"Saag","sequence":"additional","affiliation":[{"name":"Division of Clinical Immunology and Rheumatology, University of Alabama at Birmingham, Birmingham, Alabama, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Richard J.","family":"Reynolds","sequence":"additional","affiliation":[{"name":"Division of Clinical Immunology and Rheumatology, University of Alabama at Birmingham, Birmingham, Alabama, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tony R.","family":"Merriman","sequence":"additional","affiliation":[{"name":"Department of Biochemistry, University of Otago, Dunedin, New Zealand"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-20230828","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1136\/ard.2007.076232","article-title":"Gout in the UK and Germany: prevalence, comorbidities and management in general practice","volume":"67","author":"Annemans","year":"2008","journal-title":"Ann Rheum Dis"},{"key":"R2-20230828","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1002\/art.22466","article-title":"Prevalence of the metabolic syndrome in patients with gout: the Third National Health and Nutrition Examination Survey","volume":"57","author":"Choi","year":"2007","journal-title":"Arthritis Care Res"},{"key":"R3-20230828","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1016\/j.amjmed.2011.09.033","article-title":"Comorbidities of gout and hyperuricemia in the US general population: NHANES","volume":"125","author":"Zhu","year":"2012","journal-title":"Am J Med"},{"key":"R4-20230828","doi-asserted-by":"crossref","first-page":"1598","DOI":"10.1136\/annrheumdis-2014-205304","article-title":"Hyperuricaemia and gout: time for a new staging system?","volume":"73","author":"Dalbeth","year":"2014","journal-title":"Ann Rheum Dis"},{"key":"R5-20230828","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1038\/s41584-018-0004-x","article-title":"An update on the genetics of hyperuricaemia and gout","volume":"14","author":"Major","year":"2018","journal-title":"Nat Rev Rheum"},{"key":"R6-20230828","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1038\/nrrheum.2016.102","article-title":"Insight into rheumatological cause and effect through the use of Mendelian randomization","volume":"12","author":"Robinson","year":"2016","journal-title":"Nat Rev Rheum"},{"key":"R7-20230828","doi-asserted-by":"crossref","first-page":"j2376","DOI":"10.1136\/bmj.j2376","article-title":"Serum uric acid levels and multiple health outcomes: umbrella review of evidence from observational studies, randomised controlled trials, and Mendelian randomisation studies","volume":"357","author":"Li","year":"2017","journal-title":"Br Med J"},{"key":"R8-20230828","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1053\/j.ackd.2012.05.009","article-title":"Hyperuricemia hypertension","volume":"19","author":"Feig","year":"2012","journal-title":"Adv Chronic Kid Dis"},{"key":"R9-20230828","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1186\/s13075-015-0610-9","article-title":"Gout and risk of chronic kidney disease and nephrolithiasis: meta-analysis of observational studies","volume":"17","author":"Roughley","year":"2015","journal-title":"Arthritis Res Ther"},{"key":"R10-20230828","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1136\/annrheumdis-2014-205827","article-title":"Independent impact of gout on the risk of diabetes mellitus among women and men: a population-based, BMI-matched cohort study","volume":"75","author":"Rho","year":"2016","journal-title":"Ann Rheum Dis"},{"key":"R11-20230828","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1016\/j.amjcard.2012.12.034","article-title":"Association of serum uric acid and cardiovascular disease in healthy adults","volume":"111","author":"Kivity","year":"2013","journal-title":"Am J Cardiol"},{"key":"R12-20230828","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1177\/003591576505800503","article-title":"The environment and disease: association or causation?","volume":"58","author":"Hill","year":"1965","journal-title":"Proc Royal Soc Med"},{"key":"R13-20230828","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/1742-5573-1-3","article-title":"The missed lessons of Sir Austin Bradford Hill","volume":"1","author":"Phillips","year":"2004","journal-title":"Epidemiol Perspect Innov"},{"key":"R14-20230828","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1136\/annrheumdis-2013-203779","article-title":"Revisiting comorbidities in gout: a cluster analysis","volume":"74","author":"Richette","year":"2015","journal-title":"Ann Rheum Dis"},{"key":"R15-20230828","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1093\/rheumatology\/key096","article-title":"Comorbidity clusters in people with gout: an observational cohort study with linked medical record review","volume":"57","author":"Bevis","year":"2018","journal-title":"Rheumatology"},{"key":"R16-20230828","first-page":"1294","article-title":"Comorbidity patterns in gout using the US general population: cluster analysis of the National Health and Nutrition Examination Survey","volume":"78","author":"Yokose","year":"2019","journal-title":"Ann Rheum Dis"},{"key":"R17-20230828","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1093\/rheumatology\/kez105.026","article-title":"Long-term effect of allopurinol use on serum uric acid levels, mortality and comorbidities in gout patients: an electronic health record cohort study","volume":"58","author":"Rathod-Mistry","year":"2019","journal-title":"Rheumatology"},{"key":"R18-20230828","first-page":"1303","article-title":"Comorbidities in an early diagnosed cohort of uncontrolled versus controlled gout: analysis of a large US payer database","volume":"78","author":"Francis-Sedlak","year":"2019","journal-title":"Ann Rheum Dis"},{"key":"R19-20230828","first-page":"1033","article-title":"How do gout-related comorbidities and lifestyle factors cluster in a large health survey of the general population?: results from the Malm\u00f6 preventive project cohort in southern Sweden","volume":"78","author":"Fatima","year":"2019","journal-title":"Ann Rheum Dis"},{"issue":"(S10)","key":"R20-20230828","first-page":"2836","article-title":"Do serum urate-associated genetic variants differentially contribute to gout risk according to body mass index? Analysis of the UK Biobank","volume":"71","author":"Tai","year":"2019","journal-title":"Arthritis Rheumatol"},{"key":"R21-20230828","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1186\/s13075-018-1558-3","article-title":"Untangling the complex relationships between incident gout risk, serum urate, and its comorbidities","volume":"20","author":"Sun","year":"2018","journal-title":"Arthritis Res Ther"},{"key":"R22-20230828","doi-asserted-by":"crossref","first-page":"574","DOI":"10.3899\/jrheum.170806","article-title":"The rising incidence of gout and the increasing burden of comorbidities: a population-based study over 20 years","volume":"45","author":"Elfishawi","year":"2018","journal-title":"J Rheumatol"},{"key":"R23-20230828","first-page":"26","article-title":"Retrospective study of comorbidities in patients with gout","volume":"47","author":"Yang","year":"2018","journal-title":"Chongqing Med"},{"key":"R24-20230828","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/ije\/dyg070","article-title":"\u2018Mendelian randomization\u2019: can genetic epidemiology contribute to understanding environmental determinants of disease?","volume":"32","author":"Davey Smith","year":"2003","journal-title":"Int J Epidemiol"},{"key":"R25-20230828","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1093\/ije\/dyh132","article-title":"Mendelian randomization: prospects, potentials, and limitations","volume":"33","author":"Davey Smith","year":"2004","journal-title":"Int J Epidemiol"},{"key":"R26-20230828","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1136\/bmj.330.7499.1076","article-title":"What can mendelian randomisation tell us about modifiable behavioural and environmental exposures?","volume":"330","author":"Davey Smith","year":"2005","journal-title":"Br Med J"},{"key":"R27-20230828","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1002\/sim.3034","article-title":"Mendelian randomization: using genes as instruments for making causal inferences in epidemiology","volume":"27","author":"Lawlor","year":"2008","journal-title":"Stat Med"},{"key":"R28-20230828","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1093\/ije\/dyv080","article-title":"Mendelian randomization with invalid instruments: effect estimation and bias detection through Egger regression","volume":"44","author":"Bowden","year":"2015","journal-title":"Int J Epidemiol"},{"key":"R29-20230828","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1038\/s41588-018-0099-7","article-title":"Detection of widespread horizontal pleiotropy in causal relationships inferred from Mendelian randomization between complex traits and diseases","volume":"50","author":"Verbanck","year":"2018","journal-title":"Nat Genet"},{"key":"R30-20230828","doi-asserted-by":"crossref","first-page":"e1002725","DOI":"10.1371\/journal.pmed.1002725","article-title":"No causal effects of serum urate levels on the risk of chronic kidney disease: a Mendelian randomization study","volume":"16","author":"Jordan","year":"2019","journal-title":"PLoS Med"},{"key":"R31-20230828","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/j.jacc.2015.10.086","article-title":"Causal assessment of serum urate levels in cardiometabolic diseases through a Mendelian randomization study","volume":"67","author":"Keenan","year":"2016","journal-title":"J Am Coll Cardiol"},{"key":"R32-20230828","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1038\/ki.2013.353","article-title":"Mendelian randomization analysis associates increased serum urate, due to genetic variation in uric acid transporters, with improved renal function","volume":"85","author":"Hughes","year":"2014","journal-title":"Kidney Int"},{"key":"R33-20230828","doi-asserted-by":"crossref","first-page":"e39321","DOI":"10.1371\/journal.pone.0039321","article-title":"Serum uric acid and adiposity: deciphering causality using a bidirectional Mendelian randomization approach","volume":"7","author":"Lyngdoh","year":"2012","journal-title":"PLoS One"},{"key":"R34-20230828","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1161\/CIRCGENETICS.114.000556","article-title":"Mendelian randomization provides no evidence for a causal role of serum urate in increasing serum triglyceride levels","volume":"7","author":"Rasheed","year":"2014","journal-title":"Circ Cardiovasc Genet"},{"key":"R35-20230828","doi-asserted-by":"crossref","first-page":"2831","DOI":"10.1681\/ASN.2014070660","article-title":"Uric acid and cardiovascular events: a Mendelian randomization study","volume":"26","author":"Kleber","year":"2015","journal-title":"J Am Soc Nephrol"},{"key":"R36-20230828","doi-asserted-by":"crossref","first-page":"e1002937","DOI":"10.1371\/journal.pmed.1002937","article-title":"Genetically determined serum urate levels and cardiovascular and other disease in UK Biobank cohort: a phenome-wide Mendelian randomization study","volume":"16","author":"Li","year":"2019","journal-title":"PLoS Med"},{"key":"R37-20230828","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1038\/nrneph.2010.186","article-title":"Challenges of conducting a trial of uric-acid-lowering therapy in CKD","volume":"7","author":"Badve","year":"2011","journal-title":"Nature Rev Nephrol"},{"key":"R38-20230828","doi-asserted-by":"crossref","DOI":"10.1177\/2054358116675343","article-title":"A randomized controlled trial of the effects of febuxostat therapy on adipokines and markers of kidney fibrosis in asymptomatic hyperuricemic patients with diabetic nephropathy","volume":"3","author":"Beddhu","year":"2016","journal-title":"Can J Kidney Health Dis"},{"key":"R39-20230828","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1053\/j.ajkd.2018.06.028","article-title":"Febuxostat therapy for patients with stage 3 CKD and asymptomatic hyperuricemia: a randomized trial","volume":"72","author":"Kimura","year":"2018","journal-title":"Am J Kid Dis"},{"key":"R40-20230828","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1038\/s41581-019-0174-z","article-title":"The case for uric acid-lowering treatment in patients with hyperuricaemia and CKD","volume":"15","author":"Sato","year":"2019","journal-title":"Nature Rev Nephrol"},{"key":"R41-20230828","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/s41065-019-0103-y","article-title":"ABCG2 gene polymorphism rs2231142 is associated with gout comorbidities but not allopurinol response in primary gout patients of a Chinese Han male population","volume":"156","author":"Zhang","year":"2019","journal-title":"Hereditas"},{"key":"R42-20230828","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1038\/tpj.2015.101","article-title":"ABCG2 loss-of-function polymorphism predicts poor response to allopurinol in patients with gout","volume":"17","author":"Roberts","year":"2017","journal-title":"Pharmacogenomics J"},{"key":"R43-20230828","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1093\/rheumatology\/kex467","article-title":"Association between ABCG2 rs2231142 and poor response to allopurinol: replication and meta-analysis","volume":"57","author":"Wallace","year":"2018","journal-title":"Rheumatology"},{"key":"R44-20230828","doi-asserted-by":"crossref","first-page":"2145","DOI":"10.1093\/rheumatology\/key229","article-title":"Genetic association between adiposity and gout: a Mendelian randomization study","volume":"57","author":"Larsson","year":"2018","journal-title":"Rheumatology"},{"key":"R45-20230828","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/j.atherosclerosis.2012.05.036","article-title":"Associations between serum uric acid and markers of subclinical atherosclerosis in young adults. The cardiovascular risk in Young Finns study","volume":"223","author":"Oikonen","year":"2012","journal-title":"Atherosclerosis"},{"key":"R46-20230828","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1186\/s13075-018-1668-y","article-title":"The relationship between ferritin and urate levels and risk of gout","volume":"20","author":"Fatima","year":"2018","journal-title":"Arthritis Res Ther"},{"key":"R47-20230828","doi-asserted-by":"crossref","first-page":"1544","DOI":"10.1136\/annrheumdis-2018-213055","article-title":"Coffee consumption and gout: a Mendelian randomisation study","volume":"77","author":"Larsson","year":"2018","journal-title":"Ann Rheum Dis"},{"key":"R48-20230828","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1186\/s13075-018-1629-5","article-title":"Mediation analysis to understand genetic relationships between habitual coffee intake and gout","volume":"20","author":"Hutton","year":"2018","journal-title":"Arthritis Res Ther"},{"key":"R49-20230828","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1002\/ana.25294","article-title":"Mendelian randomization study shows no causal relationship between circulating urate levels and Parkinson's disease","volume":"84","author":"Kia","year":"2018","journal-title":"Ann Neurol"},{"key":"R50-20230828","doi-asserted-by":"crossref","first-page":"e13156","DOI":"10.1111\/eci.13156","article-title":"Uric acid level, gout and bone mineral density: a Mendelian randomization study","volume":"49","author":"Lee","year":"2019","journal-title":"Eur J Clin Invest"},{"key":"R51-20230828","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1002\/jbmr.2434","article-title":"Mendelian randomization analysis to examine for a causal effect of urate on bone mineral density","volume":"30","author":"Dalbeth","year":"2015","journal-title":"J Bone Mineral Res"},{"key":"R52-20230828","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1111\/1756-185X.13548","article-title":"Gout and the risk of Alzheimer\u2032 s disease: a Mendelian randomization study","volume":"22","author":"Lee","year":"2019","journal-title":"Int J Rheum Dis"},{"key":"R53-20230828","doi-asserted-by":"crossref","first-page":"3099","DOI":"10.1007\/s10067-018-4210-3","article-title":"Assessing the causal association between smoking behavior and risk of gout using a Mendelian randomization study","volume":"37","author":"Lee","year":"2018","journal-title":"Clin Rheumatol"},{"key":"R54-20230828","doi-asserted-by":"crossref","first-page":"3002","DOI":"10.2337\/db16-0418","article-title":"BMI as a modifiable risk factor for type 2 diabetes: refining and understanding causal estimates using Mendelian randomization","volume":"65","author":"Corbin","year":"2016","journal-title":"Diabetes"}],"container-title":["Current Opinion in Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/BOR.0000000000000691","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,24]],"date-time":"2023-09-24T10:27:37Z","timestamp":1695551257000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/BOR.0000000000000691"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3]]},"references-count":54,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2020]]}},"URL":"https:\/\/doi.org\/10.1097\/bor.0000000000000691","relation":{},"ISSN":["1040-8711","1531-6963"],"issn-type":[{"value":"1040-8711","type":"print"},{"value":"1531-6963","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,3]]}}}